[Neuropsychiatric pharmacotherapy, a help or a hinderance in the long term care of oligophrenic children and adolescents].
D000293:Adolescent; D002648:Child; D002657:Child Development / Q000187:drug effects; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D008607:Intellectual Disability / Q000188:drug therapy*; D008134:Long-Term Care; D011595:Psychomotor Agitation / Q000188:drug therapy; D012917:Social Adjustment; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D014149:Tranquilizing Agents
Neuropsychiatrische Pharmakotherapie, Hilfe oder Hindernis bei Langzeitbehandlung oligophrener Kinder und Jugendlicher?